NCT07276217 Phacoemulsification and Intraocular Lens Implantation: Patient Registry
| NCT ID | NCT07276217 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sensor Cliniq |
| Condition | Cataract |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-01-02 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-01-02 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to create a patient registry that will allow for comparison of cataract treatment outcomes using phacoemulsification with implantation of different types of intraocular lenses.
Eligibility Criteria
Inclusion Criteria: * Patients who have undergone cataract surgery or are scheduled for bilateral cataract surgery with implantation of an extended-depth-of-focus (EDOF) intraocular lens, a monofocal-plus intraocular lens, or a standard monofocal intraocular lens. Exclusion Criteria: * Anterior or posterior segment pathologies affecting postoperative visual acuity, including but not limited to: severe dry eye syndrome, corneal dystrophies, uveitis, retinal degenerative changes, glaucoma, or diabetic retinopathy. * Pseudoexfoliation syndrome * Keratoconus * History of laser refractive surgery * Prior ocular surgery other than cataract surgery * Amblyopia * Posterior capsule opacification * Postoperative best-corrected visual acuity (BCVA) less 0.5 * Intraoperative complications, including posterior capsule rupture
Frequently Asked Questions
Who can join the NCT07276217 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07276217 currently recruiting?
Yes, NCT07276217 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sensor Cliniq to inquire about joining.
Where is the NCT07276217 trial being conducted?
This trial is being conducted at Warsaw, Poland.
Who is sponsoring the NCT07276217 clinical trial?
NCT07276217 is sponsored by Sensor Cliniq. The trial plans to enroll 300 participants.